Stehouwer C D, Jager A, Donker A J
Academisch Ziekenhuis Vrije Universiteit, afd. Inwendige Geneeskunde, Amsterdam.
Ned Tijdschr Geneeskd. 1997 Aug 23;141(34):1649-53.
Microalbuminuria is usually defined as a urinary albumin excretion of 30-300 mg/24 h (i.e. 20-200 micrograms/min) measured, in view of the short-term variation of 15-30%, in at least 2 out of 3 urine samples. An alternative definition is: an albumin-creatinine ratio of 2-20 mg/mmol creatinine. Microalbuminuria is an indicator of an enhanced risk of chronic kidney failure and cardiovascular disease in diabetic patients and of cardiovascular disease in the elderly general population. It is not known whether these relationships exist in essential hypertension as well. In essential hypertension there is, however, a relationship between microalbuminuria and endothelial dysfunction, impaired regulation of renal haemodynamics and an increased risk of left ventricular hypertrophy and hypertensive retinopathy. By screening for microalbuminuria a group of patients can be distinguished who have a relatively high risk for the presence of complications of hypertension. It is not certain, however, that more intensive treatment of such patients (e.g. with ACE inhibitors) is useful. Consequently, for the time being, screening of patients with essential hypertension for microalbuminuria is of little practical importance.
微量白蛋白尿通常定义为尿白蛋白排泄量为30 - 300毫克/24小时(即20 - 200微克/分钟),鉴于其15 - 30%的短期变化,需在3份尿样中的至少2份中进行测量。另一种定义是:白蛋白与肌酐比值为2 - 20毫克/毫摩尔肌酐。微量白蛋白尿是糖尿病患者慢性肾衰竭和心血管疾病风险增加以及老年普通人群心血管疾病的一个指标。在原发性高血压中是否也存在这些关系尚不清楚。然而,在原发性高血压中,微量白蛋白尿与内皮功能障碍、肾血流动力学调节受损以及左心室肥厚和高血压视网膜病变风险增加之间存在关联。通过筛查微量白蛋白尿,可以区分出一组高血压并发症风险相对较高的患者。然而,目前尚不确定对这类患者进行更强化的治疗(如使用血管紧张素转换酶抑制剂)是否有用。因此,目前对原发性高血压患者进行微量白蛋白尿筛查几乎没有实际意义。